Healthcare Focus Exome Asset Management specializes in worldwide healthcare equities, suggesting opportunities to cross-sell healthcare-focused research, data analytics, or specialized alpha signals to expand the client’s sector coverage.

Growing AUM Signals With a modest team size and revenue in the mid-market range, Exome appears poised for scalable services such as outsourced portfolio analytics, risk management tooling, or fee-efficient outsourced CIO capabilities to support growth.

Recent Public Bets Recent stakes in Agios Pharmaceuticals and Gilead Sciences indicate active public market positioning in high-profile biotech names, presenting chances to offer enhanced due diligence, ESG integration, or targeted stock research subscriptions.

Awards Readiness Recognition as a Best Newcomer finalist suggests momentum and credibility; leverage this as a proof point in outreach, proposing onboarding support, client onboarding tech, and marketing services to amplify brand reach.

Digital Footprint The current tech stack includes e-commerce and form tools; there is potential to modernize client experience with secure client portals, CRM integrations, and compliance-ready workflows to attract professional assets and institutional collaborations.